- Home
- APLS vs FUL Comparison
APLS vs FUL Comparison
Compare APLS & FUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- FUL
- Stock Information
- Founded
- APLS 2009
- FUL 1887
- Country
- APLS United States
- FUL United States
- Employees
- APLS N/A
- FUL N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- FUL Home Furnishings
- Sector
- APLS Health Care
- FUL Industrials
- Exchange
- APLS Nasdaq
- FUL Nasdaq
- Market Cap
- APLS 3.3B
- FUL 3.1B
- IPO Year
- APLS 2017
- FUL N/A
- Fundamental
- Price
- APLS $18.20
- FUL $53.71
- Analyst Decision
- APLS Buy
- FUL Hold
- Analyst Count
- APLS 18
- FUL 5
- Target Price
- APLS $45.59
- FUL $62.50
- AVG Volume (30 Days)
- APLS 2.8M
- FUL 731.9K
- Earning Date
- APLS 05-06-2025
- FUL 03-26-2025
- Dividend Yield
- APLS N/A
- FUL 1.75%
- EPS Growth
- APLS N/A
- FUL N/A
- EPS
- APLS N/A
- FUL 1.99
- Revenue
- APLS $781,367,000.00
- FUL $3,546,980,000.00
- Revenue This Year
- APLS $12.71
- FUL N/A
- Revenue Next Year
- APLS $20.93
- FUL $3.50
- P/E Ratio
- APLS N/A
- FUL $26.95
- Revenue Growth
- APLS 97.02
- FUL 0.99
- 52 Week Low
- APLS $17.49
- FUL $47.56
- 52 Week High
- APLS $53.06
- FUL $87.67
- Technical
- Relative Strength Index (RSI)
- APLS 28.14
- FUL 48.41
- Support Level
- APLS $18.00
- FUL $51.62
- Resistance Level
- APLS $19.71
- FUL $54.22
- Average True Range (ATR)
- APLS 1.63
- FUL 2.73
- MACD
- APLS -0.16
- FUL 0.13
- Stochastic Oscillator
- APLS 10.98
- FUL 58.07
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About FUL H. B. Fuller Company
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.